Literature DB >> 7746774

Effect of age upon the induction and maintenance of anticoagulation with warfarin.

J R Gladman1, G Dolan.   

Abstract

We aimed to examine the effect of age upon the control of anticoagulation with warfarin in ordinary clinical practice, using a retrospective examination of routine anticoagulation clinic records from the University Hospital, Nottingham. Considerable over-anticoagulation (international normalisation ratio (INR) > 6.0) during induction occurred in 54 (11%) of 495 patients and was more likely in older patients (p < 0.05). Lesser degrees of over-anticoagulation during induction (INR > 4.0) were also more common in older patients, occurring in 58% of those aged 75 or above. Loading doses of warfarin were not reduced in older patients. INR in the maintenance phase rose with age (p < 0.001) despite lower maintenance doses of warfarin (p < 0.001). An INR > 6.0 in the maintenance phase was noted in 24 (3%) of 739 patients and again was more likely in older patients (p < 0.05). Patients using ambulance transport to the clinic were older than those who did not (p < 0.01) and those aged over 75 had shorter intervals between clinic visits (p < 0.01). We conclude that doctors using warfarin therapy do not take sufficient account of the increased sensitivity of older people to warfarin. Hospital anticoagulant policies need implementation and evaluation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7746774      PMCID: PMC2398184          DOI: 10.1136/pgmj.71.833.153

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  11 in total

1.  The association of age with dosage requirement for warfarin.

Authors:  M Redwood; C Taylor; B J Bain; J H Matthews
Journal:  Age Ageing       Date:  1991-05       Impact factor: 10.668

2.  Age as a determinant of sensitivity to warfarin.

Authors:  A M Shepherd; D S Hewick; T A Moreland; I H Stevenson
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

3.  Determinants of anticoagulant control in patients receiving warfarin.

Authors:  K O'Malley; I H Stevenson; C A Ward; A J Wood; J Crooks
Journal:  Br J Clin Pharmacol       Date:  1977-06       Impact factor: 4.335

4.  Prospective evaluation of a flexible protocol for starting treatment with warfarin and predicting its maintenance dose.

Authors:  D G Cosh; C K Moritz; K J Ashman; R J Dally; A S Gallus
Journal:  Aust N Z J Med       Date:  1989-06

5.  Warfarin therapy: need for a protocol?

Authors:  C C Harland; R P Walt
Journal:  Br J Clin Pract       Date:  1988-05

6.  Survey of use of anticoagulation in patients with atrial fibrillation.

Authors:  P M Bath; A Prasad; M M Brown; G A MacGregor
Journal:  BMJ       Date:  1993-10-23

7.  Flexible induction dose regimen for warfarin and prediction of maintenance dose.

Authors:  A Fennerty; J Dolben; P Thomas; G Backhouse; D P Bentley; I A Campbell; P A Routledge
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-28

8.  Factors affecting warfarin requirements. A prospective population study.

Authors:  P A Routledge; P H Chapman; D M Davies; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1979-06-12       Impact factor: 2.953

9.  Long-term oral anticoagulant therapy in elderly patients.

Authors:  L S Wickramasinghe; S K Basu; S K Bansal
Journal:  Age Ageing       Date:  1988-11       Impact factor: 10.668

10.  Different intensities of oral anticoagulant therapy in the treatment of proximal-vein thrombosis.

Authors:  R Hull; J Hirsh; R Jay; C Carter; C England; M Gent; A G Turpie; D McLoughlin; P Dodd; M Thomas; G Raskob; P Ockelford
Journal:  N Engl J Med       Date:  1982-12-30       Impact factor: 91.245

View more
  4 in total

Review 1.  Use of oral anticoagulants in older patients.

Authors:  J L Sebastian; D D Tresch
Journal:  Drugs Aging       Date:  2000-06       Impact factor: 3.923

Review 2.  The future prospects of pharmacogenetics in oral anticoagulation therapy.

Authors:  Farhad Kamali; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

3.  Audit of anticoagulant therapy.

Authors:  P E Rose
Journal:  J Clin Pathol       Date:  1996-01       Impact factor: 3.411

4.  Racial background is a determinant factor in the maintenance dosage of warfarin.

Authors:  Gin Gin Gan; Alan Teh; Kim Yen Goh; Heng Thay Chong; Kang Wah Pang
Journal:  Int J Hematol       Date:  2003-07       Impact factor: 2.490

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.